Tikun Olam Holdings

About:

A leading cannabis brand and globally recognized as the pioneer of modern medical cannabis.

Website: http://tikunolamusa.com/

Twitter/X: tikunolamusa

Description:

A leading cannabis brand and globally recognized as the pioneer of modern medical cannabis. The company’s global mission is to research, develop and provide efficacious, data-based cannabis treatments to help sufferers. Operating as a commercial venture for over ten years, Tikun Olam’s products have been used since 2010 in ongoing clinical trials in Israel’s regulated medical cannabis market, treating over 10,000 patients for a variety of symptoms of medical conditions such as Cancer, PTSD, AIDS, epilepsy, Crohn’s Disease/Colitis, multiple sclerosis, cerebral palsy, chronic pain and neuropathy.

Total Funding Amount:

$25M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Wilmington, Delaware, United States

Founded Date:

2016-10-01

Contact Email:

info(AT)firststatecompassion.com

Founders:

Yitzhak Cohen

Number of Employees:

11-50

Last Funding Date:

2018-11-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai